mal and malignant epithelial cells and several other cell The c-met proto-oncogene encodes the tyrosine kinase types, including endothelial cells and melanocytes. 4,5 receptor for hepatocyte growth factor (HGF), a potent It has been reported that the expression of c-Met is enmitogen and motogen for
Hepatocyte growth factor receptor and the c-Met oncogene
β Scribed by Nelson Fausto
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 429 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The c-met proto-oncogene encodes the tyrosine kinase receptor for hepatocyte growth factor (HGF), a potent mitogen and motogen for epithelial cells. Because of its profound effects on cell growth and motility, HGF may be important in the development of cancer metastases in hepatocellular carcinoma (
Hepatocyte growth factor (HGF) and its receptor c-met are present in several human tissues but their expression in mesothelial cells has not been examined. In this study, we have investigated the expression of HGF and c-met in normal human mesothelial cells and 11 human malignant mesothelioma cell l
## Abstract The receptor for the hepatocyte growth factor/scatter factor (HGF/SF), cβMet, plays a role in tumour promotion, progression and metastasis. In this study, we analysed chemically induced hepatocarcinogenesis in mice lacking a functional HGF receptor in their liver. Control and cβMet defi
## Background: This study was designed to evaluate the significance of tumor angiogenesis and angiogenic factors such as hepatocyte growth factor (hgf) and c-met in determining the prognoses of 93 patients with endometrial carcinoma. ## Methods: By immunohistochemical staining, this retrospective
## Abstract ## BACKGROUND. Hepatocyte growth factor (HGF) is a multipotent cytokine that is mediated by its receptor, cβMET. HGF/cβMET contributes to tumor progression in many human malignancies; however, HGF/cβMET is inversely correlated with aggressive biologic behavior in other cancers. Convers